{
    "nct_id": "NCT03226821",
    "official_title": "Body Composition and Adipose Tissue in HIV Lipodystrophy: Effects of Tesamorelin Therapy",
    "inclusion_criteria": "* HIV-infected subjects with HIV lipodystrophy (HIVLD)\n* Abdominal fat accumulation defined as: Waist Circumference (WC) 102 cm for men, 88 cm for women, except in subjects of East/South Asian ethnicity in whom this will be defined by WC 90 cm for men and 80 cm for women.\n* Weight stable for 8 weeks prior to enrollment,\n* CD4 count >100 cells/mm3\n* HIV RNA load <1000 copies/mL\n* Fasting plasma glucose <120 mg/dL\n* Stable combination anti-retroviral therapy (cART) of any regimen for â‰¥ 8 weeks prior to study enrollment\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 68 Years",
    "exclusion_criteria": "* Diabetes mellitus requiring medication\n* History of any malignancy\n* Abnormal renal or liver function\n* Pregnancy or women of childbearing age who are not using an acceptable means of contraception\n* History disorder of the hypothalamic-pituitary axis due to hypophysectomy, hypopituitarism or pituitary tumor/surgery\n* Head irradiation or head trauma or adrenal insufficiency\n* Systemic glucocorticoid use\n* Known hypersensitivity to tesamorelin and/or mannitol",
    "miscellaneous_criteria": ""
}